Rethinking Phase I: Five Strategies for Faster Proof of Concept

For emerging biotechs, the goal isn't just speed—it's reaching strategic milestones with the data needed to make go/no-go decisions. To navigate the complexities of early development, companies must prioritize capital efficiency and clinical precision.

Join our Clinical Trialblazers expert panel as they share strategies for streamlining Phase I programs and identifying your most promising assets sooner and maximizing the value of your development program.

In this webinar, you'll:

• Understand which innovative trial designs actually work
• Learn how to deliver defensible go/no-go decisions in weeks through modernized data operations
• Discover how to navigate global regulatory complexity early to de-risk your development path
• Explore when and how to leverage AI and advanced modeling to accelerate timelines
• Identify the operational bottlenecks that drain capital and delay critical decisions